4//SEC Filing
Diaz Stephanie 4
Accession 0001493152-24-006048
CIK 0001357459other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 3:08 PM ET
Size
21.4 KB
Accession
0001493152-24-006048
Insider Transaction Report
Form 4
Diaz Stephanie
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-08−6,980→ 0 total→ Common Stock (6,980 underlying) - Exercise/Conversion
Common Stock, par value $0.01
2024-02-08+6,980→ 6,980 total - Exercise/Conversion
Restricted Stock Units
2024-02-08−5,820→ 0 total→ Common Stock (5,820 underlying) - Exercise/Conversion
Common Stock Options
2024-02-08+9,580→ 9,580 totalExercise: $1.60From: 2023-06-11Exp: 2033-06-11→ Common Stock (9,580 underlying) - Exercise/Conversion
Common Stock, par value $0.01
2024-02-08+5,820→ 12,800 total - Exercise/Conversion
Common Stock Options
2024-02-08−6,880→ 0 totalExercise: $0.59From: 2023-11-21Exp: 2033-11-21→ Common Stock (6,880 underlying) - Exercise/Conversion
Common Stock Options
2024-02-08−9,580→ 0 totalExercise: $1.60From: 2023-06-11Exp: 2033-06-11→ Common Stock (9,580 underlying) - Exercise/Conversion
Common Stock Options
2024-02-08+6,880→ 6,880 totalExercise: $0.59From: 2023-11-21Exp: 2033-11-21→ Common Stock (6,880 underlying)
Footnotes (8)
- [F1]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
- [F2]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on November 21, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
- [F3]This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding.
- [F4]This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding.
- [F5]Each restricted stock unit represents the right to receive one share of common stock.
- [F6]Each option represents the right to purchase one share of common stock at the exercise price.
- [F7]Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.
- [F8]Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001850265
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 3:08 PM ET
- Size
- 21.4 KB